Diagnostic performance of CD66c in lung adenocarcinoma-associated malignant pleural effusion: comparison with CEA, CA 19-9, and CYFRA 21-1. Issue 2 (February 2015)
- Record Type:
- Journal Article
- Title:
- Diagnostic performance of CD66c in lung adenocarcinoma-associated malignant pleural effusion: comparison with CEA, CA 19-9, and CYFRA 21-1. Issue 2 (February 2015)
- Main Title:
- Diagnostic performance of CD66c in lung adenocarcinoma-associated malignant pleural effusion
- Authors:
- Son, Seung-Myoung
Han, Hye-Suk
An, Jin Young
Choe, Kang Hyeon
Lee, Ki Man
Lee, Ki Hyeong
Kim, So-Seul
Lee, Yong-Moon
Lee, Ho-chang
Song, Hyung Geun
Lee, Ok-Jun - Abstract:
- Abstract : Summary: Various tumour markers have been evaluated in malignant pleural effusions, but not CD66c. This study evaluated the diagnostic ability of CD66c in lung adenocarcinoma-associated malignant pleural effusions (LA-MPEs) and compared it with other known tumour markers. Forty-seven cases of LA-MPE and 52 cases of benign pleural effusions were collected. The levels of CD66c, CEA, CA 19-9, and CYFRA 21-1 were measured by enzyme immunoassay. The expression of CD66c, CEA, and CA 19-9 in cell blocks was measured by immunocytochemistry. CEA had the best diagnostic values, with a sensitivity of 87.2% and specificity of 92.3%. Both CD66c and CA 19-9 showed the highest specificity of 98.1%, with sensitivities of 63.8% and 55.3%, respectively. CYFRA 21-1 had a sensitivity of 83.0% and specificity of 76.9%. CEA combined with CA 19-9 reached a sensitivity of 91.5% and a specificity of 98.1%. The sensitivities of immunocytochemical staining for CD66c, CEA, and CA 19-9 were 72.5%, 75%, and 40%, respectively. CD66c showed a diagnostic performance comparable to CYFRA 21-1 and CA 19-9 by enzyme immunoassay. Immunocytochemical study showed that CD66c and CEA were more sensitive than CA19-9. Both studies support CD66c as a potential tumour marker to differentiate LA-MPE from benign effusions. Abstract : Supplemental Digital Content is available in the text
- Is Part Of:
- Pathology. Volume 47:Issue 2(2015:Feb.)
- Journal:
- Pathology
- Issue:
- Volume 47:Issue 2(2015:Feb.)
- Issue Display:
- Volume 47, Issue 2 (2015)
- Year:
- 2015
- Volume:
- 47
- Issue:
- 2
- Issue Sort Value:
- 2015-0047-0002-0000
- Page Start:
- Page End:
- Publication Date:
- 2015-02
- Subjects:
- CA 19 -- CD66c -- CEA -- CEACAM6 -- CYFRA 21 -- lung adenocarcinoma -- pleural effusion
Pathology -- Periodicals
616.0705 - Journal URLs:
- http://informahealthcare.com/loi/pat ↗
http://journals.lww.com/pathologyrcpa/pages/issuelist.aspx ↗
http://pathologyjournal.rcpa.edu.au/ ↗
http://journals.lww.com ↗
http://www.tandf.co.uk/journals/titles/00313025.asp ↗ - DOI:
- 10.1097/PAT.0000000000000215 ↗
- Languages:
- English
- ISSNs:
- 0031-3025
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6412.810000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 5165.xml